Charles Schwab Investment Management Inc Arbutus Biopharma Corp Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,212,246 shares of ABUS stock, worth $3.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,212,246
Previous 380,583
218.52%
Holding current value
$3.85 Million
Previous $1.18 Million
296.85%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ABUS
# of Institutions
155Shares Held
99.5MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$69 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$40.9 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$36.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$28.4 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$26.7 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $477M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...